ACHV241220C5000
- 0.06
- 0.000.00%
Achieve Life Newsroom
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12
Express News | Rodman & Renshaw Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $12
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Achieve Life Sciences Poised for U.S. Launch of Cytisinicline With Strong Financial and Strategic Foundations
Maxim Group Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $10
Achieve Life Sciences: Promising Future With Strategic Leadership and Strong Financial Position Justifies Buy Rating
Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript Summary
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Oppenheimer Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Express News | Achieve Life Sciences Inc Files for Offering of up to 3.5 Mln Common Shares by Selling Stockholders - SEC Filing
Achieve Life | 10-Q: Q3 2024 Earnings Report
Achieve Life | 8-K: Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Achieve Life Sciences GAAP EPS of -$0.36 Misses by $0.09
Express News | Achieve Life Sciences Q3 Net Income USD -12.512 Million Vs. IBES Estimate USD -9.18 Million
Achieve Life Sciences 3Q Loss/Shr 36c >ACHV
Here Are the Major Earnings After the Close Today
Earnings Preview: Achieve Life to Report Financial Results Post-market on November 07